- $191.14m
- $121.54m
- $59.63m
- 46
- 28
- 73
- 47
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.67 | ||
| Price to Tang. Book | 2.76 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.21 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -57.11% | ||
| Return on Equity | -51.56% | ||
| Operating Margin | -128.65% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 26.89 | 42.21 | 46.85 | 50.23 | 59.63 | 55.17 | 65.57 | 27.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.
Directors
- E. Kevin Hrusovsky NEC (60)
- Kevin Knopp PRE (48)
- Christopher Brown CFD (46)
- Joseph Griffith CFO (46)
- Michele Fournier CHO
- Michael Turner VPR (54)
- Trent Basarsky VPR (53)
- John Kenneweg VPR (48)
- Marcia Eisenberg DRC
- Nicolas Barthelemy IND (55)
- Keith Crandell IND (61)
- Fenel Eloi IND (63)
- Jeffrey George IND (47)
- Mark Spoto IND (52)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 10th, 2012
- Public Since
- December 18th, 2020
- No. of Shareholders
- 33
- No. of Employees
- 246
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Market- Shares in Issue
- 35,329,993
- Address
- 645 Summer Street, BOSTON, 02210
- Web
- https://908devices.com/
- Phone
- +1 9787294478
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for MASS
Q1 2025 908 Devices Inc. Earnings Release
908 Devices Inc. Annual Shareholders Meeting
Q2 2025 908 Devices Inc. Earnings Release
Similar to MASS
Alpha Teknova
NASDAQ Global Market
Anteris Technologies Global
NASDAQ Global Market
AtriCure
NASDAQ Global Market
Beta Bionics
NASDAQ Global Market
Brainsway
NASDAQ Global Market
FAQ
What is the 908 Devices share price?
As of Today at 19:01 UTC, shares in 908 Devices are trading at $5.41. This share price information is delayed by 15 minutes.
How has the 908 Devices share price performed this year?
Shares in 908 Devices last closed at $5.41 and the price had moved by -2.7% over the past 365 days. In terms of relative price strength the 908 Devices share price has underperformed the S&P500 Index by -10.19% over the past year.
What are the analyst and broker recommendations for 908 Devices?
The overall consensus recommendation for 908 Devices is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the 908 Devices dividend yield?
908 Devices does not currently pay a dividend.
Does 908 Devices pay a dividend?
908 Devices does not currently pay a dividend.
When does 908 Devices next pay dividends?
908 Devices does not currently pay a dividend.
How do I buy 908 Devices shares?
To buy shares in 908 Devices you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of 908 Devices?
As of the previous close price of $5.41, shares in 908 Devices had a market capitalisation of $191.14m.
Where are 908 Devices shares listed?
Here are the trading details for 908 Devices:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: MASS
What kind of share is 908 Devices?
Based on an overall assessment of its quality, value and momentum 908 Devices is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a 908 Devices share price forecast for 2025?
The analyst consensus target price for shares in 908 Devices is $5.50. That is 1.66% above the last closing price of $5.41.
Analysts covering 908 Devices currently have a consensus Earnings Per Share (EPS) forecast of -$0.94 for the next financial year.
Find out moreWhat is the trend in the 908 Devices share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 908 Devices. Over the past six months, its share price has outperformed the S&P500 Index by +73.32%.
As of the last closing price of $5.41, shares in 908 Devices were trading +55.48% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the 908 Devices PE Ratio?
The 908 Devices PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $5.41.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of 908 Devices?
908 Devices' management team is headed by:
- E. Kevin Hrusovsky - NEC
- Kevin Knopp - PRE
- Christopher Brown - CFD
- Joseph Griffith - CFO
- Michele Fournier - CHO
- Michael Turner - VPR
- Trent Basarsky - VPR
- John Kenneweg - VPR
- Marcia Eisenberg - DRC
- Nicolas Barthelemy - IND
- Keith Crandell - IND
- Fenel Eloi - IND
- Jeffrey George - IND
- Mark Spoto - IND